Bivision Pharma
PrivateLast Round
Series A
Jul 26, 2024
Total Funding Raised
$28.6M
Company Overview
Bivision Pharma operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series A round in July 2024.
Bivision Pharma is a biotechnology company that develops targeted radiopharmaceuticals for the diagnosis and treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bivision Pharma Comparables
Compare Bivision Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convergent Therapeutics | 87% | |
| Full-Life Technologies|Home | 86% | |
| Eli Lilly and Company | 85% |
For institutional investors. Book with your work email.
Bivision Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 26, 2024 | ||||
| VC Round | May 14, 2024 | ||||
| Angel | May 1, 2022 |
For institutional investors. Book with your work email.
Bivision Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 华金大道投资有限公司 | Series A |
| Kaitai Capital | Angel |
| Huajin Capital | Series A |
| Gaorong Capital | Series A, Angel, VC Round |
| Hongli Innovation Investment | Angel, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2024
$14M round led by Huajin Capital and 华金大道投资有限公司
- May 14, 2024
Led by Gaorong Capital and Hongli Innovation Investment.
For institutional investors. Book with your work email.
Bivision Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bivision Pharma's valuation, stock price, and market status.
Is Bivision Pharma a public or private company?
Bivision Pharma is a private company.
What is the current stock price of Bivision Pharma?
Bivision Pharma is a private company, so its shares have no public market price. Caplight tracks Bivision Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bivision Pharma worth (valuation)?
Valuation information for Bivision Pharma is not publicly available.
Can I buy Bivision Pharma stock?
Bivision Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bivision Pharma's last funding round?
Bivision Pharma's most recent funding round was Series A on July 26, 2024.
Who are the main investors in Bivision Pharma?
Key investors in Bivision Pharma include 华金大道投资有限公司, Huajin Capital, Gaorong Capital, Hongli Innovation Investment.
Will Bivision Pharma IPO soon?
No public IPO plans have been announced for Bivision Pharma.
How can I track Bivision Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Bivision Pharma's shares on secondary markets.